Extended Data Fig. 6: Pathway analysis in CTCs upon treatment with digoxin.

Top 30 enriched pathways (over-representation analysis adjusted P value < 0.05) among downregulated (top) and upregulated (bottom) genes in circulating tumor cells (CTCs) deriving from blood samples post-digoxin intake.